Cancer Research SABCS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH SEARCH RESULT
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Therapeutics and Targets: Identification, Validation, and Markers

Contributing journals to this collection:
Cancer Prevention Journals Portal, Cancer Prevention Journals Portal Content, , Cancer Reviews Online, Molecular Cancer Research, Cancer Prevention Research, Molecular Cancer Therapeutics, Cancer Research, Cancer Reviews Online Content, Clinical Cancer Research, and Cancer Epidemiology Biomarkers & Prevention

Citations 51-60 of 90 total displayed.

Past content

Clin. Cancer Res.
Reviews
Aurora Kinases: New Targets for Cancer Therapy
Richard D. Carvajal, Archie Tse, and Gary K. Schwartz
Clin. Cancer Res. 2006; 12: 6869-6875. [Abstract] [Full text] [PDF]  

Clin. Cancer Res.
Review
Synopsis of a Roundtable on Validating Novel Therapeutics for Multiple Myeloma
William Dalton and Kenneth C. Anderson
Clin. Cancer Res. 2006; 12: 6603-6610. [Abstract] [Full text] [PDF]  

Cancer Res.
Reviews
Targeting Prostaglandin E EP Receptors to Inhibit Metastasis
Amy M. Fulton, Xinrong Ma, and Namita Kundu
Cancer Res. 2006; 66: 9794-9797. [Abstract] [Full text] [PDF]  

Clin. Cancer Res.
Review
Protein Kinase C as a Therapeutic Target
Beverly A. Teicher
Clin. Cancer Res. 2006; 12: 5336-5345. [Full text] [PDF]  

Cancer Res.
Reviews
Regulatory T Cells and Toll-Like Receptors in Cancer Therapy
Rong-Fu Wang
Cancer Res. 2006; 66: 4987-4990. [Abstract] [Full text] [PDF]  

Cancer Res.
Reviews
The Phosphoinositide 3-Kinase/Akt1/Par-4 Axis: A Cancer-Selective Therapeutic Target
Anindya Goswami, Padhma Ranganathan, and Vivek M. Rangnekar
Cancer Res. 2006; 66: 2889-2892. [Abstract] [Full text] [PDF]  

Mol. Cancer Ther.
Review
Targeted therapy by disabling crossroad signaling networks: the survivin paradigm
Dario C. Altieri
Mol. Cancer Ther. 2006; 5: 478-482. [Abstract] [Full text] [PDF]  

Mol. Cancer Ther.
Review
Sphingolipid targets in cancer therapy
David E. Modrak, David V. Gold, and David M. Goldenberg
Mol. Cancer Ther. 2006; 5: 200-208. [Abstract] [Full text] [PDF]  

Cancer Res.
Reviews
Type I Insulin-like Growth Factor Receptor as a Therapeutic Target in Cancer
Bradley S. Miller and Douglas Yee
Cancer Res. 2005; 65: 10123-10127. [Abstract] [Full text] [PDF]  

Mol. Cancer Ther.
Minireview
PRL phosphatases as potential molecular targets in cancer
Bret J. Stephens, Haiyong Han, Vijay Gokhale, and Daniel D. Von Hoff
Mol. Cancer Ther. 2005; 4: 1653-1661. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9

* Collected Resources Home


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH SEARCH RESULT
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2009 by the American Association for Cancer Research.